@article{11beca583af84d538d000377c6d498a2,
title = "Added value of drug-laboratory test interaction alerts in test result authorisation",
keywords = "Clinical Decision Support System (CDSS), Diagnostic error, Drug-laboratory test interaction (DLTI), Laboratory test, Patient safety, NLA",
author = "{van Balveren}, {Jasmijn A.} and {Verboeket-van de Venne}, {Wilhelmine P.H.G.} and Doggen, {Carine J.M.} and Lale Erdem-Eraslan and {de Graaf}, {Albert J.} and Krabbe, {Johannes G.} and Musson, {Ruben E.A.} and Oosterhuis, {Wytze P.} and {De Rijke}, {Yolanda B.} and {van der Sijs}, Heleen and Tintu, {Andrei N.} and Verheul, {Rolf J.} and Hoedemakers, {Rein M.J.} and Ron Kusters",
note = "Funding Information: Research funding: This study received funding from Stichting Kwaliteitsgelden Medisch Specialisten (SKMS), grant number 42678870. ",
year = "2022",
month = apr,
day = "26",
doi = "10.1515/cclm-2022-0077",
language = "English",
volume = "60",
pages = "E108--E111",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter",
number = "5",
}